Clinical trials are essential in vaccine development to ensure safety and effectiveness. They include:
Phase I: Safety and dosage testing on a small group.
Phase II tests how practical and toxicity is in a broader group.
Phase III: confirms efficacy and monitors reactions in diverse populations.
Phase IV is post-marketing surveillance for long-term safety.
These trials are essential for public health, and the World Vaccines R&D Conference promotes global vaccine research and collaboration.